Renumathy Dhanasekaran, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 7
Offices
7 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dhanasekaran’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A136461 · Current
Licensed to practise in California · since 2015 · expires 2028-08-31 · Rajiv Gandhi University of Health Sciences, Bangalore Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$43,968
Medicare paid this office $43,968 for 174 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 78 | $24,985 | $150 |
| New patient visit (60+ min) | 32 | $5,531 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,081 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,324 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,481 | $114 |
See all 7 services
| Long return visit (40+ min) | 78 | $24,985 | $150 |
| New patient visit (60+ min) | 32 | $5,531 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,081 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,324 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,481 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,389 | $116 |
| Measurement of liver stiffness | 21 | $189 | $9 |
Procedures Medicare counted
| Colonoscopy | 11 | More than 41% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 23 | More than 52% of doctors who do this |
Who their Medicare patients are
174 Original Medicare patients in 2024. Average age 70 · Women 54% · Also on Medicaid 43% · Health risk score 2.53. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 41% · Chronic kidney disease 38% · Coronary heart disease 30% · Heart failure 28% · Atrial fibrillation 23% · COPD 17% · Depression 17% · Cancer 16% · Dementia 9% · Stroke 7%.
The office billed $244,520, Medicare allowed $57,602 and paid $43,968; for 332 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 174 | 332 | 70 | 2.53 | $244,520 | $43,968 |
| 2023 | 164 | 336 | 70 | 2.94 | $199,126 | $37,439 |
| 2022 | 93 | 168 | 68 | 3.21 | $96,605 | $14,958 |
| 2021 | 50 | 85 | 67 | 2.51 | $62,520 | $9,033 |
| 2020 | 24 | 41 | 70 | 2.57 | $19,040 | $3,753 |
| 2019 | 59 | 93 | 67 | 3.45 | $35,823 | $8,941 |
| 2018 | 103 | 200 | 67 | 2.71 | $81,752 | $20,265 |
| 2017 | 84 | 195 | 66 | 2.89 | $105,045 | $18,997 |
| 2016 | 42 | 81 | 67 | 1.54 | $83,459 | $9,316 |
| 2015 | 20 | 21 | 68 | 3.16 | $2,591 | $1,585 |
| 2014 | 66 | 107 | 68 | 1.67 | $14,527 | $9,194 |
| 2013 | 75 | 108 | 68 | 1.71 | $15,067 | $9,760 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $10,414 | $110 |
| Long return visit (40+ min) | 45 | $9,509 | $127 |
| New patient visit (60+ min) | 35 | $5,458 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,913 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,757 | $160 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $962 | $87 |
| Return visit (30+ min) | 12 | $720 | $60 |
| Measurement of liver stiffness | 13 | $126 | $10 |
2022: 5 services
| Return visit (30+ min) | 32 | $3,807 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,055 | $93 |
| New patient visit (45+ min) | 11 | $1,417 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,370 | $65 |
| Short return visit (20+ min) | 12 | $778 | $56 |
2021: 1 service
| Return visit (30+ min) | 15 | $2,088 | $80 |
2020: 1 service
| Long return visit (40+ min) | 14 | $2,152 | $94 |
2019: 2 services
| Long return visit (40+ min) | 23 | $3,288 | $87 |
| New patient visit (60+ min) | 15 | $2,261 | $151 |
2018: 3 services
| Long return visit (40+ min) | 33 | $5,485 | $91 |
| Long return visit (40+ min) | 20 | $3,060 | $99 |
| New patient visit (60+ min) | 15 | $2,258 | $151 |
2017: 3 services
| Long return visit (40+ min) | 33 | $7,134 | $96 |
| New patient visit (45+ min) | 20 | $2,195 | $110 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $91 | $5 |
2016: 1 service
| Long return visit (40+ min) | 11 | $1,288 | $92 |
2015: 1 service
| Return visit (30+ min) | 12 | $928 | $77 |
2014: 2 services
| Return visit (30+ min) | 37 | $4,032 | $76 |
| New patient visit (45+ min) | 25 | $3,014 | $121 |
2013: 3 services
| Return visit (30+ min) | 36 | $3,759 | $77 |
| New patient visit (45+ min) | 32 | $3,582 | $112 |
| Long return visit (40+ min) | 14 | $1,311 | $94 |
Medicaid work
$3,912 in 2024
Medicaid paid $3,912 for 58 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 58 | $3,912 |
| 2024 | 58 | 1 | 15 | $3,912 |
| 2023 | 115 | 1 | 24 | $4,517 |
| 2022 | 26 | 1 | 12 | $798 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 115 | $4,517 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $798 |
Drugs they prescribed that Part D paid
$120,152
Pharmacies billed $120,152 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
188 generic and fewer than 11 brand-name prescriptions · $120,152 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 11 | $13,814 | $1,256 |
| Ursodiol | 15 | $1,497 | $100 |
| Furosemide | 26 | $92 | $4 |
| Spironolactone | 16 | $67 | $4 |
| Torsemide | 11 | $64 | $6 |
Year by year
| 2024 | 223 | 48 | None | None | $120,152 |
| 2023 | 77 | 28 | 17% (13) | None | $154,910 |
| 2022 | 70 | 24 | None | 23% | $34,731 |
| 2021 | 115 | 23 | 0% (0) | 37% | $80,684 |
| 2020 | 98 | 19 | 0% (0) | 19% | $21,254 |
| 2019 | 161 | 32 | None | 7% | $27,518 |
| 2018 | 258 | 41 | None | 14% | $153,803 |
| 2017 | 140 | 34 | None | None | $57,122 |
| 2016 | 57 | 26 | None | 30% | $31,302 |
| 2015 | 99 | 30 | None | 39% | $140,578 |
| 2014 | 185 | 42 | 12% (22) | 45% | $266,905 |
| 2013 | 93 | 31 | None | 33% | $16,977 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Furosemide | 11 | $31 | $3 |
2021: 3 drugs
| Xifaxan | 27 | $76,333 | $2,827 |
| Entecavir | 16 | $1,507 | $94 |
| Lactulose | 33 | $1,146 | $35 |
2020: 2 drugs
| Entecavir | 22 | $1,969 | $90 |
| Furosemide | 18 | $58 | $3 |
2019: 4 drugs
| Entecavir | 16 | $2,985 | $187 |
| Tacrolimus | 24 | $928 | $39 |
| Bumetanide | 11 | $869 | $79 |
| Lactulose | 13 | $140 | $11 |
2018: 11 drugs
| Xifaxan | 14 | $47,862 | $3,419 |
| Entecavir | 28 | $8,644 | $309 |
| Tacrolimus | 13 | $598 | $46 |
| Spironolactone | 18 | $338 | $19 |
| Pantoprazole | 19 | $105 | $6 |
| Mirtazapine | 13 | $88 | $7 |
| Furosemide | 14 | $65 | $5 |
| Hydroxyzine | 15 | $51 | $3 |
| Glipizide | 12 | $31 | $3 |
| Amlodipine Besylate | 12 | $24 | $2 |
| Metoprolol | 12 | $17 | $1 |
2017: 4 drugs
| Nadolol | 12 | $719 | $60 |
| Lactulose | 16 | $225 | $14 |
| Glipizide | 17 | $73 | $4 |
| Furosemide | 12 | $69 | $6 |
2015: 2 drugs
| Humira | 13 | $83,088 | $6,391 |
| Omeprazole | 11 | $209 | $19 |
2014: 6 drugs
| Humira | 13 | $70,397 | $5,415 |
| Budesonide Ec | 14 | $17,461 | $1,247 |
| Creon | 11 | $2,816 | $256 |
| Omeprazole | 13 | $302 | $23 |
| Tramadol | 20 | $228 | $11 |
| Furosemide | 12 | $52 | $4 |
2013: 1 drug
| Omeprazole | 11 | $291 | $26 |
Money from drug and device companies
$1,611 in 2025
| 2025 | 1 | 1 | $1,611 | $1,611 |
| 2022 | 2 | 3 | None | $210 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Imfinzi | $1,611 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Consulting · 2025-11-25 | Imfinzi | $1,611 |
See earlier years (2022)
2022: $210
| Gilead Sciences | None | $123 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $87 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1609008143
- Licence
- CA 136461, MN 106149, MN 55597California A136461: Current · expires 2028-08-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- MN ENROLLED
- Taxonomy
- Federal specialty code 207RT0003X (207RT0003X); Internal medicine (207R00000X); Federal specialty code 207RG0100X (207RG0100X); Federal specialty code 207RI0008X (207RI0008X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-08-18
- NPI last updated
- 2025-02-25
- NPI record certified
- 2025-02-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 1st St Sw, Rochester, MN, 55905